TNF and chronic kidney disease: Contemporary comparative data from a multicenter Japanese cohort similarly suggested a renal benefit signal with TNF blockade: TNF inhibitors were linked to a lower CKD incidence than CTLA4-Ig (abatacept) (HR 0.67, 95% CI 0.46–0.97) [53].